These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 18045779

  • 1. Overview of targeted therapies in oncology.
    Kalyn R.
    J Oncol Pharm Pract; 2007 Dec; 13(4):199-205. PubMed ID: 18045779
    [Abstract] [Full Text] [Related]

  • 2. Review: side effects of approved molecular targeted therapies in solid cancers.
    Widakowich C, de Castro G, de Azambuja E, Dinh P, Awada A.
    Oncologist; 2007 Dec; 12(12):1443-55. PubMed ID: 18165622
    [Abstract] [Full Text] [Related]

  • 3. Targeted therapies: a nursing perspective.
    Kay P.
    Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):1-4. PubMed ID: 16616280
    [Abstract] [Full Text] [Related]

  • 4. Targeted therapies: aiming for the bull's-eye.
    Gaguski ME.
    ONS Connect; 2007 Jul; 22(7):8-12. PubMed ID: 17694778
    [No Abstract] [Full Text] [Related]

  • 5. Targeted therapies: a new generation of cancer treatments.
    Gerber DE.
    Am Fam Physician; 2008 Feb 01; 77(3):311-9. PubMed ID: 18297955
    [Abstract] [Full Text] [Related]

  • 6. Nanoparticle and targeted systems for cancer therapy.
    Brannon-Peppas L, Blanchette JO.
    Adv Drug Deliv Rev; 2004 Sep 22; 56(11):1649-59. PubMed ID: 15350294
    [Abstract] [Full Text] [Related]

  • 7. Novel targets for therapy in paediatric oncology.
    Estlin EJ.
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul 22; 2(2):141-50. PubMed ID: 12476788
    [Abstract] [Full Text] [Related]

  • 8. [Molecular-targeted therapy for malignant glioma].
    Yamanaka R.
    Brain Nerve; 2009 Feb 22; 61(2):177-88. PubMed ID: 19235468
    [Abstract] [Full Text] [Related]

  • 9. Molecular-targeted therapies: lessons from years of clinical development.
    Rosa DD, Ismael G, Lago LD, Awada A.
    Cancer Treat Rev; 2008 Feb 22; 34(1):61-80. PubMed ID: 17826917
    [Abstract] [Full Text] [Related]

  • 10. Molecular targeting and gene delivery in bladder cancer therapy.
    Voutsinas GE, Stravopodis DJ.
    J BUON; 2009 Sep 22; 14 Suppl 1():S69-78. PubMed ID: 19785072
    [Abstract] [Full Text] [Related]

  • 11. Rational targeting of Notch signaling in cancer.
    Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L.
    Oncogene; 2008 Sep 01; 27(38):5124-31. PubMed ID: 18758481
    [Abstract] [Full Text] [Related]

  • 12. Potential role of vascular targeted therapy to combat against tumor.
    Chen B, Jin H, Wu K.
    Expert Opin Drug Deliv; 2009 Jul 01; 6(7):719-26. PubMed ID: 19538038
    [Abstract] [Full Text] [Related]

  • 13. Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery.
    Bouzin C, Feron O.
    Drug Resist Updat; 2007 Jun 01; 10(3):109-20. PubMed ID: 17452119
    [Abstract] [Full Text] [Related]

  • 14. Molecularly targeted agents: their promise as cancer chemopreventive interventions.
    Thiery-Vuillemin A, Nguyen T, Pivot X, Spano JP, Dufresnne A, Soria JC.
    Eur J Cancer; 2005 Sep 01; 41(13):2003-15. PubMed ID: 16098739
    [Abstract] [Full Text] [Related]

  • 15. New approaches in metastatic melanoma: biological and molecular targeted therapies.
    Lejeune FJ, Rimoldi D, Speiser D.
    Expert Rev Anticancer Ther; 2007 May 01; 7(5):701-13. PubMed ID: 17492933
    [Abstract] [Full Text] [Related]

  • 16. The future of targeted therapies in ovarian cancer.
    Banerjee S, Gore M.
    Oncologist; 2009 Jul 01; 14(7):706-16. PubMed ID: 19592450
    [Abstract] [Full Text] [Related]

  • 17. Small molecule inhibitors in children with malignant gliomas.
    Herrington B, Kieran MW.
    Pediatr Blood Cancer; 2009 Sep 01; 53(3):312-7. PubMed ID: 19434732
    [Abstract] [Full Text] [Related]

  • 18. Antiangiogenic therapy using nanotechnological-based delivery system.
    Kanwar JR, Mahidhara G, Kanwar RK.
    Drug Discov Today; 2011 Mar 01; 16(5-6):188-202. PubMed ID: 21262383
    [Abstract] [Full Text] [Related]

  • 19. Pancreatic cancer: from molecular pathogenesis to targeted therapy.
    Strimpakos A, Saif MW, Syrigos KN.
    Cancer Metastasis Rev; 2008 Sep 01; 27(3):495-522. PubMed ID: 18427734
    [Abstract] [Full Text] [Related]

  • 20. Emerging drugs for esophageal cancer.
    Homs MY, Voest EE, Siersema PD.
    Expert Opin Emerg Drugs; 2009 Jun 01; 14(2):329-39. PubMed ID: 19453287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.